Tagreed Alkaltham: Apheresis – Precision in Blood Component Collection
Tagreed Alkaltham, Transfusion Medicine Lab Supervisor at KSMC, shared a post on LinkedIn:
”Apheresis: Precision in Blood Component Collection
Not all blood donations are the same.
Some are designed… with precision.
Apheresis is a specialized donation process that allows us to collect specific blood components while safely returning the rest to the donor.
Because in transfusion medicine, efficiency is not a luxury… it’s a necessity.
Platelet Apheresis (Single Donor Platelets):
Platelets are critical for patients with:
- Cancer
- Bone marrow failure
- Massive bleeding
With apheresis:
- We collect a high dose platelet unit from a single donor
- Reducing donor exposure for the patient
- Enhancing transfusion safety and compatibility
One donor. One therapeutic dose. One controlled outcome.
Plasma Apheresis:
Plasma carries:
- Clotting factors
- Proteins essential for survival
Used in:
- Trauma and massive transfusion
- Liver disease
- Plasma exchange therapies
With apheresis:
- We collect larger plasma volumes efficiently
- While maintaining donor safety
Supporting critical care… with targeted collection.
Red Cell Apheresis (Double RBC Collection):
Designed for:
- Patients with chronic transfusion needs
- Situations requiring specific blood types
With this method:
- We collect two units of red cells in one session
- From a single, eligible donor
Maximizing impact… without increasing donor burden.
Why Apheresis Matters?
Because it allows us to:
- Improve component quality
- Reduce patient exposure to multiple donors
- Optimize inventory during shortages
- Deliver targeted therapy, not just transfusion
Apheresis is not just a technique.
It is a reflection of how far transfusion medicine has evolved
- From collection…
- to precision driven care.
In modern blood banking, we don’t just collect blood… we design it to meet the patient’s exact need.”
Other posts featuring Tagreed Alkaltham on Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy